StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
0809.HK$0.06-1.67%
Fair $0.06+0.0%

0809.HK

Global Bio-chem Technology Group Company Limited

Consumer Defensive / Packaged FoodsHKSE

$0.06

-0.00 (-1.67%)

Fairly Valued+0.0%Fair Value $0.06Fund rank 26/100 · Data gapFallback financials|
SA 40/C
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-28.4M · quality 45.3/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 14/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -30.1%, below the 5% threshold
Thesis & Journal · 0809.HKLocal privado en este navegador · Global Bio-chem Technology Group Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.0B

P/E

6.0x

↓

EV/EBITDA

5.9x

↓

ROE

-30.1%

↓

Gross Margin

8.6%

↓

Debt/Equity

-3.46

↓
52-Week Range$0
$0$0

TradingView lightweight chart

0809.HK price, volumen y niveles de valoración

Último $0.059Periodo -91.8%
Fair value: $0.060

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+463.8%

FCF CAGR

—

FCF margin

-1.2%

FCF / Net income

-0.18x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.28B · net income $156.3M · FCF $-28.4M

2022-FY → 2025-FY

Gross margin

8.6%-49.0% pts

Operating margin

-3.4%+2042.3% pts

Net margin

6.9%+11359.8% pts

FCF margin

-1.2%+739.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.28B$2.28B$2.00B$1.37B$12.7M
Net Income$156.3M$156.3M$769.6M$4.22B$-1.44B
EBITDA$578.2M$578.2M$1.30B$4.76B$-409.3M
EPS0.010.010.030.29-0.16
Gross Margin8.6%8.6%9.5%3.2%57.7%
Operating Margin-3.4%-3.4%-4.8%-23.8%-2045.7%
Net Margin6.9%6.9%38.5%307.5%-11352.9%
Balance Sheet
Debt/Equity-3.46-3.46-1.36-1.09-1.08
Current Ratio0.490.49———
Cash Flow
Free Cash Flow$-28.4M$-28.4M$76.0M$-94.2M$-94.2M
Returns
ROE-30.1%-30.1%-39.4%-104.6%19.1%
Valuation
P/E6.006.003.550.43—
EV/EBITDA5.855.854.061.28—
Growth & Yield
Revenue Growth13.9%13.9%45.6%10709.0%—
EPS Growth-79.3%-79.3%-90.0%279.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-3.9%

fácil

EPS terminal req.

$0.01

Spread vs growth

-75.4%

5Y implied EPS CAGR

1.4%

fácil

EPS terminal req.

$0.01

Spread vs growth

-80.7%

10Y implied EPS CAGR

5.6%

razonable

EPS terminal req.

$0.01

Spread vs growth

-84.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -18.1%

Total return

-18.1%

Start / end P/E

2.5x → 9.8x

EPS bridge

0.03 → 0.01

Residual

-234.8%

EPS growth-79.3%
Multiple rerating+296.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term-234.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.